Aandelen in “Farmaceutica”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
AbbVie |
10/01 | 175,170 USD
-1,87% |
-1,87% |
|
AC Immune SA |
10/01 | 2,720 USD
-2,86% |
-2,86% |
|
Adc Therapeutics SA |
10/01 | 1,880 USD
-2,08% |
-2,08% |
|
Addex Therapeutics Ltd |
10/01 | 7,520 USD
-7,05% |
-7,05% |
Addex Therapeutics Ltd |
10/01 | 0,064 CHF
+6,31% |
+6,31% |
|
Adial Pharmaceuticals Inc |
10/01 | 1,020 USD
0,00% |
0,00% |
|
Adicet Bio Inc |
10/01 | 0,917 USD
-4,47% |
-4,47% |
Aequus Pharmaceuticals Inc |
10/01 | 0,010 CAD
0,00% |
0,00% |
|
Aileron Therapeutics Inc |
10/01 | 2,110 USD
+9,33% |
+9,33% |
|
Akari Therapeutics Plc |
10/01 | 1,215 USD
-5,08% |
-5,08% |
|
Akero Therapeutics Inc |
10/01 | 24,840 USD
-5,05% |
-5,05% |
|
Aligos Therapeutics Inc |
10/01 | 33,710 USD
-12,19% |
-12,19% |
|
Allakos Inc |
10/01 | 0,969 USD
-1,06% |
-1,06% |
|
Amneal Pharmaceuticals Inc |
10/01 | 7,970 USD
-1,12% |
-1,12% |
|
Amneal Pharmaceuticals Inc - Class A |
10/01 | 7,970 USD
-1,12% |
-1,12% |
|
Annexon Inc |
10/01 | 4,830 USD
-0,21% |
-0,21% |
|
Annovis Bio Inc |
10/01 | 4,890 USD
-5,23% |
-5,23% |
|
Apellis Pharmaceuticals Inc |
10/01 | 27,440 USD
-16,85% |
-16,85% |
|
Appili Therapeutics Inc |
10/01 | 0,035 CAD
+16,67% |
+16,67% |
|
Applied Dna Sciences Inc |
10/01 | 0,198 USD
+0,20% |
+0,20% |
|
Applied Therapeutics Inc |
10/01 | 0,679 USD
-6,40% |
-6,40% |
|
Aprea Therapeutics Inc |
10/01 | 3,655 USD
-7,23% |
-7,23% |
|
Aptorum Group Ltd. |
10/01 | 1,390 USD
-2,80% |
-2,80% |
|
Aquestive Therapeutics Inc |
10/01 | 3,080 USD
-1,60% |
-1,60% |
|
Arcturus Therapeutics Holdings Inc |
10/01 | 17,980 USD
-5,12% |
-5,12% |
|
Arcus Biosciences Inc |
10/01 | 14,200 USD
-4,83% |
-4,83% |
|
Arcutis Biotherapeutics Inc |
10/01 | 13,810 USD
-9,56% |
-9,56% |
|
Aridis Pharmaceuticals Inc |
8/01 | 0,000 USD
0,00% |
0,00% |
|
Assertio Holdings Inc |
10/01 | 0,836 USD
+0,69% |
+0,69% |
|
AstraZeneca |
10/01 | 67,010 USD
+0,65% |
+0,65% |
AstraZeneca |
10/01 | 10.982,000 GBX
-0,05% |
-0,05% |
|
Atea Pharmaceuticals Inc |
10/01 | 3,270 USD
-2,10% |
-2,10% |
|
Avenue Therapeutics Inc |
10/01 | 1,811 USD
-2,61% |
-2,61% |